Association of polymorphic markers Arg753Gln in the TLR2 Gene, T-1237C and G2848A in the TLR9 Gene with the risk of developing primary adrenal insufficiency in individuals living in the Moscow Region of the Russian Federation

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. Primary adrenal insufficiency (PAI) is an endocrine disorder caused by the gradual destruction of all three layers of the adrenal cortex and characterized by insufficient secretion of cortisol and aldosterone. This condition significantly reduces patients’ quality of life, making its timely diagnosis crucial. Autoimmune disorders are the etiological factor in approximately 80% of PAI cases, making the search for predictive markers in innate immune genes one of the most promising areas for predicting the odds of developing PAI. Aims — to study the associations between single nucleotide polymorphisms in the TLR2 and TLR9 genes and the development of PAI. Methods. The study included 222 individuals: 72 patients with PAI and 150 controls. For the study, DNA was isolated from venous blood and subsequently analyzed using real-time PCR with fluorescently labeled probes. Statistical analysis of the results was performed using Fisher’s exact test (Fi), the χ2 test, the χ2 test with Yates’ correction, calculation of the odds ratio and 95% confidence interval. Results. The study revealed that the A allele (p < 0.001) and the heterozygous genotype (p < 0.001) of the rs5743708 polymorphism in the TLR2 gene were associated with the risk of developing PAI. Conversely, the homozygous genotype GG (p < 0.001) reduced the odds of the pathology development by 11-fold. Analysis of the rs352140 single nucleotide polymorphism in the TLR9 gene also demonstrated an association between the A allele (p = 0.030) and the homozygous AA genotype (p = 0.0171) with the odds of developing PAI. Conclusions. Based on the data obtained in this and our previous study, a scheme was proposed that includes four polymorphic markers to predict the odds of developing 1-HH.

Full Text

Restricted Access

About the authors

Ekaterina A. Meremianina

I. Mechnikov Research Institute of Vaccines and Sera

Author for correspondence.
Email: ekaterina@meremianina.ru
ORCID iD: 0000-0003-4334-1473
SPIN-code: 9721-4839

MD, PhD

Russian Federation, Moscow

Ekaterina A. Troshina

Endocrinology Research Centre

Email: troshina.ekaterina@endocrincentr.ru
ORCID iD: 0000-0002-8520-8702
SPIN-code: 8821-8990

MD, PhD, Professor, Corresponding Member of the RAS

Russian Federation, Moscow

Marina Yu. Yukina

Endocrinology Research Centre

Email: Yukina.Marina@endocrincentr.ru
ORCID iD: 0000-0002-8771-8300
SPIN-code: 4963-8340

MD, PhD

Russian Federation, Moscow

Nurana F. Nuralieva

Endocrinology Research Centre

Email: nuralieva.nurana@endocrincentr.ru
ORCID iD: 0000-0001-6876-3336
SPIN-code: 7373-2602

MD, PhD

Russian Federation, Moscow

Natalia O. Kalyuzhnaya

I. Mechnikov Research Institute of Vaccines and Sera

Email: nat_kalyuzhnaya@mail.ru
ORCID iD: 0000-0002-1668-1846
SPIN-code: 7169-6807
Russian Federation, Moscow

Natalya D. Abramova

I. Mechnikov Research Institute of Vaccines and Sera

Email: and960911@gmail.com
ORCID iD: 0000-0002-7307-0515
SPIN-code: 1763-8942

MD, PhD

Russian Federation, Moscow

Nadezhda D. Rasskazova

I. Mechnikov Research Institute of Vaccines and Sera

Email: neonovita@mail.ru
ORCID iD: 0000-0003-0729-5940
SPIN-code: 8940-6505
Russian Federation, Moscow

Ilia N. Diakov

I. Mechnikov Research Institute of Vaccines and Sera

Email: dyakov.ilya@gmail.com
ORCID iD: 0000-0001-5384-9866
SPIN-code: 1854-0958

PhD (Biology)

Russian Federation, Moscow

Oksana A. Svitich

I. Mechnikov Research Institute of Vaccines and Sera

Email: svitichoa@yandex.ru
ORCID iD: 0000-0003-1757-8389
SPIN-code: 8802-5569

MD, PhD, Professor, Academician of the RAS

Russian Federation, Moscow

References

  1. Xiong T, Wang R, Zhou J, et al. Case Report: Adrenal tuberculosis causing primary adrenal insufficiency: diagnosis by ultrasound-guided biopsy. Front Med (Lausanne). 2025;12:1622617. doi: https://doi.org/10.3389/fmed.2025.1622617
  2. Russell G, Kalafatakis K, Durant C, et al. Ultradian hydrocortisone replacement alters neuronal processing, emotional ambiguity, affect and fatigue in adrenal insufficiency: The PULSES trial. J Intern Med. 2024;295(1):51–67. doi: https://doi.org/10.1111/joim.13721
  3. Liu Y, Yin H, Zhao M, et al. TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol. 2014;47(2):136–147. doi: https://doi.org/10.1007/s12016-013-8402-y
  4. Inoue N, Katsumata Y, Watanabe M, et al. Polymorphisms and expression of toll-like receptors in autoimmune thyroid diseases. Autoimmunity. 2017;50(3):182–191. doi: https://doi.org/10.1080/08916934.2016.1261835
  5. Zhao L, Du S, Xu W, et al. Genetic variants of Toll-like receptor 9 are associated with susceptibility to systemic lupus erythematosus in Han Chinese female patients. Peer J. 2025;13:e19847. doi: https://doi.org/10.7717/peerj.19847
  6. Rael VE, Yano JA, Huizar JP, et al. Large-scale mutational analysis identifies UNC93B1 variants that drive TLR-mediated autoimmunity in mice and humans. J Exp Med. 2024;221(8):e20232005. doi: https://doi.org/10.1084/jem.20232005
  7. Lee MS, Kim DH, Lee JC, et al. Role of TLR2 in the pathogenesis of autoimmune diabetes and its therapeutic implication. Diabetes Metab Res Rev. 2011;27(8):797–801. doi: https://doi.org/10.1002/dmrr.1231
  8. Jafarzadeh A, Nemati M, Khorramdelazad H, et al. The Toll-like Receptor 2 (TLR2)-related Immunopathological Responses in the Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Iran J Allergy Asthma Immunol. 2019;18(3):230–250. doi: https://doi.org/10.18502/ijaai.v18i3.1117
  9. Smelaya TV, Belopolskaya OB, Smirnova SV, et al. Genetic dissection of host immune response in pneumonia development and progression. Sci Rep. 2016;6:35021. doi: https://doi.org/10.1038/srep35021
  10. Лукьянова С.О., Артемьева О.В., Насаева Е.Д., и др. Ассоциация полиморфизма гена TLR2 Arg753Gln с уровнем его экспрессии у долгожителей с синдромом старческой астении // Медицинская иммунология. — 2024. — Т. 26. — № 4. — С. 711–716. [Lukyanova SO, Artemieva OV, Nasaeva ED, et al. Association of TLR2 Arg753Gln gene polymorphism with its expression level in nonagenarians with frailty. Russian Journal of Immunology (Russia). 2024;26(4):711–716. (In Russ.)] doi: https://doi.org/10.15789/1563-0625-AOT-16697
  11. Moura EL, Santos IFD, Freitas PP, et al. Polymorphisms in Toll-like receptors genes changes the host’s immune response and is associated with cervical cancer. Immunobiology. 2022;227(2):152187. doi: https://doi.org/10.1016/j.imbio.2022.152187
  12. Carvalho A, Osório NS, Saraiva M, et al. The C Allele of rs5743836 Polymorphism in the Human TLR9 Promoter Links IL-6 and TLR9 Up-Regulation and Confers Increased B-Cell Proliferation. PLoS One. 2011;6(11):e28256. doi: https://doi.org/10.1371/journal.pone.0028256
  13. Shi G, Wang T, Li S, et al. TLR2 and TLR4 polymorphisms in Southern Chinese Psoriasis Vulgaris patients. J Dermatol Sci. 2016;83(2):145–147. doi: https://doi.org/10.1016/j.jdermsci.2016.04.014
  14. Abdelbaset NE, Khattab SS, Abd Elbaky NM, et al. Association between TLR-2 and TLR-9 gene polymorphisms (rs5743708 and rs5743836) and susceptibility to psoriatic arthritis in Egyptian patients. Egypt J Immunol. 2025;32(1):77–91. doi: https://doi.org/10.55133/eji.320108
  15. dos Santos BP, Valverde JV, Rohr P, et al. TLR7/8/9 polymorphisms and their associations in systemic lupus erythematosus patients from southern Brazil. Lupus. 2012;21(3):302–309. doi: https://doi.org/10.1177/0961203311425522
  16. Zhang J, Zhu Q, Meng F, et al. Association study of TLR-9 polymorphisms and systemic lupus erythematosus in northern Chinese Han population. Gene. 2014;533(1):385–388. doi: https://doi.org/10.1016/j.gene.2013.08.051
  17. Wang Y, Xia Y, Chen Y, et al. Association analysis between the TLR9 gene polymorphism rs352140 and type 1 diabetes. Front Endocrinol (Lausanne). 2023;14:1030736. doi: https://doi.org/10.3389/fendo.2023.1030736
  18. De Re V, Repetto O, De Zorzi M, et al. Polymorphism in Toll-Like Receptors and Helicobacter Pylori Motility in Autoimmune Atrophic Gastritis and Gastric Cancer. Cancers (Basel). 2019;11(5):648. doi: https://doi.org/10.3390/cancers11050648

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Distribution of allele frequencies (A) and genotypes (B) of the polymorphic marker rs5743708 in the TLR2 gene in groups with primary adrenal insufficiency and in the control group

Download (142KB)
3. Fig. 2. Distribution of allele frequencies (A) and genotypes (B) of the polymorphic marker rs352140 in the TLR9 gene in groups with primary adrenal insufficiency and in the control group

Download (134KB)
4. Fig. 3. General scheme of the association of the studied polymorphic markers with the risk of developing 1-HH in individuals living in the Moscow region of the Russian Federation

Download (241KB)

Copyright (c) 2026 "Paediatrician" Publishers LLC

License URL: https://vestnikramn.spr-journal.ru/jour/about/submissions